CenterBook Partners LP Invests $301,000 in Addus HomeCare Corporation (NASDAQ:ADUS)

CenterBook Partners LP acquired a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 3,046 shares of the company's stock, valued at approximately $301,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Natixis increased its stake in Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the period. Meeder Asset Management Inc. bought a new stake in Addus HomeCare during the fourth quarter worth about $77,000. Harvest Fund Management Co. Ltd acquired a new position in shares of Addus HomeCare during the fourth quarter worth approximately $86,000. Cibc World Markets Corp acquired a new position in shares of Addus HomeCare during the fourth quarter worth approximately $204,000. Finally, Bailard Inc. acquired a new position in shares of Addus HomeCare during the first quarter worth approximately $208,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Insider Buying and Selling

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at $896,540. This represents a 20.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Macquarie reiterated an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a report on Wednesday. Seven analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $142.57.

Addus HomeCare Stock Down 2.4%

Shares of NASDAQ:ADUS traded down $2.66 during midday trading on Friday, reaching $107.03. 136,336 shares of the company were exchanged, compared to its average volume of 166,386. The firm has a market cap of $1.97 billion, a PE ratio of 24.16, a P/E/G ratio of 1.52 and a beta of 0.81. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The stock has a fifty day simple moving average of $112.44 and a two-hundred day simple moving average of $109.91. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. The business had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. Addus HomeCare's quarterly revenue was up 20.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.21 EPS. As a group, sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.